Specificity of a Prodrug-Activating Enzyme hVACVase: The Leaving Group Effect
- 28 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (6), 2362-2368
- https://doi.org/10.1021/mp100300k
Abstract
Human valacyclovirase (hVACVase) is a prodrug-activating enzyme for amino acid prodrugs including the antiviral drugs valacyclovir and valganciclovir. In hVACVase-catalyzed reactions, the leaving group of the substrate corresponds to the drug moiety of the prodrug, making the leaving group effect essential for the rational design of new prodrugs targeting hVACVase activation. In this study, a series of valine esters, phenylalanine esters, and a valine amide were characterized for the effect of the leaving group on the efficiency of hVACVase-mediated prodrug activation. Except for phenylalanine methyl and ethyl esters, all of the ester substrates exhibited a relatively high specificity constant (kcat/Km), ranging from 850 to 9490 mM−1·s−1. The valine amide Val-3-APG exhibited significantly higher Km and lower kcat values compared to the corresponding ester Val-3-HPG, indicating poor specificity for hVACVase. In conclusion, the substrate leaving group has been shown to affect both binding and specific activity of hVACVase-catalyzed activation. It is proposed that hVACVase is an ideal target for α-amino acid ester prodrugs with relatively labile leaving groups while it is relatively inactivate toward amide prodrugs.Keywords
This publication has 14 references indexed in Scilit:
- Enhancing the Intestinal Absorption of Molecules Containing the Polar Guanidino Functionality: A Double-Targeted Prodrug ApproachJournal of Medicinal Chemistry, 2009
- Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapyBritish Journal of Pharmacology, 2006
- Nucleoside Ester Prodrug Substrate Specificity of Liver CarboxylesteraseJournal of Pharmacology and Experimental Therapeutics, 2005
- Lessons Learned from Marketed and Investigational ProdrugsJournal of Medicinal Chemistry, 2004
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- A Novel Nucleoside Prodrug-Activating Enzyme: Substrate Specificity of Biphenyl Hydrolase-like ProteinMolecular Pharmaceutics, 2004
- Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug designJournal of Antimicrobial Chemotherapy, 2003
- Identification of a Human ValacycloviraseJournal of Biological Chemistry, 2003
- Targeted prodrug design to optimize drug deliveryAAPS PharmSci, 2000
- Catalytic Properties of an Unspecific Carboxylesterase (E1) from Rat‐Liver MicrosomesEuropean Journal of Biochemistry, 1973